B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis

Keyphrases

• B Cells 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Glatiramer Acetate 100%
• Multiple Sclerosis 30%
• T Cells 10%
• Mechanism of Action 10%
• Dendritic Cells 10%
• Macrophages 10%
• Protective Effect 10%
• Gene-deficient Mice 10%
• Autoimmune Disease 10%
• Evidence Support 10%
• Ovalbumin 10%
• T Helper 17 (Th17) 10%
• Treatment Effect 10%
• Regulatory T Cells 10%
• Autoreactive T Cells 10%
• Costimulatory Molecules 10%
• Specific T Cells 10%
• Nervous System Diseases 10%
• Approved Drugs 10%
• Th1 Cells 10%
• Safety Profile 10%
• Reduced Expression 10%
• Multiple Sclerosis Treatment 10%
• CD80 10%
• CD86 10%
• IL-10 Production 10%
• CD11b+ 10%
• Good Safety 10%
• IL-10 Expression 10%
• Myelin Oligodendrocyte Glycoprotein 10%
• MOG35-55 10%

Immunology and Microbiology

• Mouse 100%
• B Cell 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Glatiramer Acetate 100%
• T Cell 27%
• Multiple Sclerosis 27%
• Dendritic Cell 9%
• Macrophage 9%
• Central Nervous System 9%
• Autoimmune Disease 9%
• Regulatory T Cell 9%
• Th1 Cell 9%
• CD80 9%
• Co-Stimulatory Molecule 9%
• CD86 9%
• Th17 Cell 9%
• Treatment of Multiple Sclerosis 9%
• Myelin Oligodendrocyte Glycoprotein 9%